LENZ
LENZ Therapeutics
LENZ
LENZ
145 hedge funds and large institutions have $303M invested in LENZ Therapeutics in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 28 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 47
46% less capital invested
Capital invested by funds: $562M → $303M (-$258M)
54% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $2.41M
Holders
145
Holding in Top 10
3
Calls
$1.1M
Puts
$2.41M
Top Buyers
| 1 | +$14.3M | |
| 2 | +$9.37M | |
| 3 | +$6.08M | |
| 4 |
Morgan Stanley
New York
|
+$5.84M |
| 5 |
BOCH
Blue Owl Capital Holdings
New York
|
+$5.01M |
Top Sellers
| 1 | -$19.9M | |
| 2 | -$13.8M | |
| 3 | -$9.12M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.9M |
| 5 |
NAMI
Nomura Asset Management International
Philadelphia,
Pennsylvania
|
-$6.38M |
